Form 4: ANI Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Muthusamy Shanmugam, Head of R&D and COO-Novitium Ops at ANI Pharmaceuticals, disposed of shares to cover tax obligations related to vesting restricted stock.

Summary

• On February 29, 2024, Muthusamy Shanmugam, Head of R&D and COO-Novitium Ops at ANI Pharmaceuticals, disposed of 1,122 shares of common stock at a price of $67.67 per share to cover tax obligations.
• This transaction was exempt under Rule 16(b)-3 and related to the vesting of 4,342 shares of restricted stock previously reported.
• Following the transaction, Shanmugam directly owns 68,652 shares of ANI Pharmaceuticals common stock.
• Shanmugam also indirectly owns 882,620 shares through Esjay LLC and 5,000 shares through SS Pharma LLC, over which he holds voting and dispositive power.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive sold shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a change in sentiment towards the company.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of trading by corporate insiders. This filing indicates that an executive at ANI Pharmaceuticals sold shares, likely to cover tax obligations related to vested stock awards. This is a common practice and doesn't necessarily indicate a negative outlook on the company.

Key Dates